Industry-Validated, Proprietary Platform

AbTherx has initiated over 50 programs with more than 25 partners in the past 12 months, on our patented platform developed by industry-leading experts in transgenic mice.

Fit-for-Partner Business Model

We build durable collaborations rooted in a deep understanding of our partners’ goals to create long-term value for both parties. Our flexible business terms—from milestone- and royalty-free structures to pay-upon-success models—are designed to meet you where you are today and scale with you as your needs evolve.

Tailored Access

AbTherx offers customized engagement models to support academic innovators, biotech startups, and established pharma companies. Whether you’re building internal capabilities or seeking external expertise, you have flexible access points to our technology.

• Platform transfer: Order Atlas Mice globally for in-house discovery programs through The Jackson Laboratory
• Outsourced discovery: Work with our preferred CROs for full-service antibody discovery
• Strategic collaborations: Work with AbTherx to co-develop new assets, access early-stage technologies, and advance structure-based discovery

Proven Expertise

Our team of scientific pioneers has over 20 years of expertise in antibody discovery, transgenic mouse development, immunogen design, and challenging drug targets at Medarex, BMS and Zai Labs, resulting in over 1,000 successful antibody discovery campaigns and 13 marketed therapeutics.

Contact us to explore how AbTherx can power your next antibody discovery program.